Ken Jones, COO Europe, Astellas joins GSK, Shire, Takeda and Bausch & Lomb on value based selling panel session

Emirates PharmaAdvertisement

With one week to go SFE Europe shows no sign of slowing down. With over 550 confirmed attendees and an a 80% ratio from within industry- it looks like the best networking option for sales and marketing pharmaceutical executives in 2011.  Ken Jones, COO Europe, Astellas has just confirmed SFE Europe’s keynote value based selling panel session. He will be joining: Charl Van Zyl, VP & GM, Bausch and Lomb, Michael Zaiac, VP, GSK & Charlotte Sibley, SVP, Shire. It’s the only place this year that they will be speaking together on the same subject.

The key learning points are below:

• How do organizations create unique value for their most strategic B2B customers?
• Value-based selling: strategies and enablers for successful key account management
• How can pharma manufacturers generate win/wins for their key customers?

Here’s what a few of the SFE 2011 current delegates are saying about this years meeting: 

“This is the most comprehensive pharma SFE event in Europe. It also provides the attendees the unique opportunity to follow the latest trends in SFE related topics and to form a face-to-face network with key industry personalities, colleagues, and service providers”
Can Sunata, Astellas , 2011 attendee

“I want to attend this event to benchmark ourselves against the rest of the industry, see how others approach common issues”
Michael Crawford, Leo Pharama, 2011 attendee

“I am keen in understanding differences in Sale Force Effectiveness concepts between the Australian and European Markets. I will bring back these learning’s and apply them to my team here in Australia” George Polimenakos, Norgine, 2011 attendee

For more information visit: www.sfeeurope.com

Media contact:
Mike Stoneman
Global Marketing Coordinator
Eyeforpharma
+44 (0)20 7375 7559
mstoneman@eyeforpharma.com

Emirates PharmaAdvertisement